Genmab A (GMAB) Change in Cash (2023 - 2026)

Genmab A has reported Change in Cash for 4 years, with the latest figure at -$183.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 179.22% year-over-year to -$183.0 million; the trailing twelve-month figure through Mar 2026 stood at $335.0 million (up 135.75% YoY), and the FY2025 full-year result was $332.0 million, up 137.43% from the prior year.
• Change in Cash for Q1 2026 stood at -$183.0 million, down from $374.0 million in the prior quarter.
• The five-year high for Change in Cash was $1.3 billion in Q3 2024, with the low at -$3.5 billion in Q4 2023.
• Historically, Change in Cash has averaged -$488.4 million across 4 years, with a median of -$87.0 million in 2025.
• Annual changes were most pronounced in 2025 — Change in Cash jumped 403.95% — and 2026, when it plunged 179.22%.
• Genmab A's Change in Cash stood at -$3.5 billion in 2023, then soared by 74.56% to -$887.0 million in 2024, then jumped by 142.16% to $374.0 million in 2025, then sank by 148.93% to -$183.0 million in 2026.
• The last three Change in Cash figures came in at -$183.0 million (Q1 2026), $374.0 million (Q3 2025), and -$87.0 million (Q2 2025), per Business Quant data.